{"title": "Una vacuna china prueba con \u00e9xito su seguridad y capacidad para generar anticuerpos", "author": "The Objective", "url": "https://theobjective.com/sociedad/2020-05-22/una-vacuna-china-prueba-con-exito-su-seguridad-y-capacidad-para-generar-anticuerpos/", "hostname": "theobjective.com", "description": "La carrera por conseguir una vacuna efectiva contra el coronavirus, en la que ya participan m\u00e1s de 100 candidatas, est\u00e1 dando sus primeros resultados concluyentes. Seg\u00fan publica la revista m\u00e9dica The Lancet, la primera vacuna en alcanzar la fase 1 del ensayo cl\u00ednico, desarrollada por la compa\u00f1\u00eda china Cansino Biologics, es segura,tolerablepor el organismo humano y capaz de generar anticuerposen el mismo.", "sitename": "The Objective", "date": "2020-05-22", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Una vacuna china prueba con \u00e9xito su seguridad y capacidad para generar anticuerpos\nEl prop\u00f3sito de la primera fase de los ensayos, en la que ya se encuentran dos vacunas, es probar que el organismo las tolera\nLa carrera por conseguir una vacuna efectiva contra el coronavirus, en la que ya participan m\u00e1s de 100 candidatas, est\u00e1 dando sus primeros resultados concluyentes. Seg\u00fan\n[publica la revista m\u00e9dica ](https://www.eurekalert.org/pub_releases/2020-05/tl-tlf052220.php)The Lancet, la primera vacuna en alcanzar la fase 1 del ensayo cl\u00ednico, desarrollada por la compa\u00f1\u00eda china [Cansino Biologics](http://www.cansinotech.com/homes/article/show/56/153.html), es segura, tolerable por el organismo humano y capaz de generar anticuerpos en el mismo.\nEl pasado lunes, la compa\u00f1\u00eda estadounidense Moderna anunci\u00f3 los resultados de una prueba con 45 voluntarios y la calificaban de \u00absegura y bien tolerada\u00bb por los mismos. El prop\u00f3sito de la primera fase de los ensayos cl\u00ednicos, en la que se encuentran ambas vacunas, es probar, precisamente, que el organismo las tolera bien.\nTras 28 d\u00edas de ensayo con 108 voluntarios sanos, los resultados son prometedores: una dosis de la vacuna produce, en 14 d\u00edas, no solo anticuerpos, si no tambi\u00e9n linfocitos T.\u00abSin embargo, los resultados deben ser interpretados con cautela. Los desaf\u00edos en el desarrollo de una vacuna contra el COVID-19 son in\u00e9ditos, y la habilidad para generar una respuesta inmune no indica necesariamente que la vacuna proteger\u00e1 a los humanos del coronavirus\u00bb, ha alertado la cient\u00edfica Wei Chen, del Beijing Institute of Biotechnology, responsable del estudio publicado.\nLa vacuna de Cansino Biologicas utiliza un virus de catarro com\u00fan atenuado, que invade las c\u00e9lulas humanas sin provocar en ellas la enfermedad, actuando as\u00ed como medio para introducir en las c\u00e9lulas del paciente el material gen\u00e9tico que codifica las prote\u00ednas que forman las esp\u00edculas con las que el SARS-CoV-2 entra en las c\u00e9lulas. Despu\u00e9s, esas c\u00e9lulas producen la prote\u00edna, que llega al sistema inmune de quien recibe la vacuna y le permite crear anticuerpos que despu\u00e9s reconocer\u00e1n esa esp\u00edcula e impedir\u00e1n la infecci\u00f3n.", "language": null, "image": "https://theobjective.com/wp-content/uploads/2020/05/una-vacuna-china-prueba-con-exito-su-seguridad-y-capacidad-para-generar-anticuerpos.jpg", "pagetype": "article", "links": ["https://theobjective.com", "https://theobjective.com/newsletters", "https://theobjective.com/apoya-a-the-objective", "https://theobjective.com", "https://theobjective.com", "https://theobjective.com/newsletters", "https://theobjective.com/apoya-a-the-objective", "https://theobjective.com", "https://twitter.com/TheObjective_es", "https://www.instagram.com/theobjective_Es/", "https://www.facebook.com/theobjective.esp", "https://www.youtube.com/c/TheObjective_es", "https://open.spotify.com/user/theobjective_es?si=m4YyKsRFSKaAd11iC1pJrA", "https://es.linkedin.com/company/the-objective-media", "https://medium.com/@TheObjective", "https://www.tiktok.com/@theobjective", "https://theobjective.com/", "https://theobjective.com/espana/", "https://theobjective.com/etiqueta/elecciones-generales/", "https://theobjective.com/espana/politica/", "https://theobjective.com/espana/tribunales/", "https://theobjective.com/espana/andalucia/", "https://theobjective.com/etiqueta/cataluna/", "https://theobjective.com/espana/castilla-y-leon/", "https://theobjective.com/etiqueta/comunidad-de-madrid/", "https://theobjective.com/etiqueta/comunidad-valenciana/", "https://theobjective.com/etiqueta/pais-vasco/", "https://theobjective.com/economia/", "https://theobjective.com/etiqueta/macroeconomia/", "https://theobjective.com/etiqueta/telecos/", "https://theobjective.com/etiqueta/energia/", "https://theobjective.com/etiqueta/transporte/", "https://theobjective.com/etiqueta/banca/", "https://theobjective.com/economia/consumo/", "https://theobjective.com/elsubjetivo/", "https://theobjective.com/elsubjetivo/opinion/", "https://theobjective.com/autor/alvaro-nieto/", "https://theobjective.com/autor/felix-de-azua/", "https://theobjective.com/autor/fernando-savater/", "https://theobjective.com/autor/antonio-cano/", "https://theobjective.com/cultura/", "https://theobjective.com/etiqueta/literatura/", "https://theobjective.com/etiqueta/musica/", "https://theobjective.com/etiqueta/cine/", "https://theobjective.com/etiqueta/arte/", "https://theobjective.com/etiqueta/series/", "https://theobjective.com/sociedad/", "https://theobjective.com/etiqueta/salud/", "https://theobjective.com/sociedad/medioambiente/", "https://theobjective.com/lifestyle/", "https://theobjective.com/etiqueta/moda/", "https://theobjective.com/etiqueta/belleza/", "https://theobjective.com/etiqueta/sexualidad/", "https://theobjective.com/gastronomia/", "https://theobjective.com/etiqueta/recetas/", "https://theobjective.com/etiqueta/vinos/", "https://theobjective.com/etiqueta/restaurantes/", "https://theobjective.com/gente/", "https://theobjective.com/etiqueta/celebrities/", "https://theobjective.com/etiqueta/casa-real/", "https://theobjective.com/internacional/", "https://theobjective.com/etiqueta/guerra-ucrania-rusia/", "https://theobjective.com/deportes/", "https://theobjective.com/etiqueta/futbol/", "https://theobjective.com/etiqueta/formula-1/", "https://theobjective.com/etiqueta/baloncesto/", "https://theobjective.com/etiqueta/tenis/", "https://theobjective.com/etiqueta/golf/", "https://theobjective.com/motor/", "https://theobjective.com/etiqueta/coches/", "https://theobjective.com/etiqueta/motos/", "https://theobjective.com/etiqueta/movilidad/", "https://theobjective.com/etiqueta/dgt/", "https://theobjective.com/tecnologia/", "https://theobjective.com/tecnologia/videojuegos/", "https://theobjective.com/etiqueta/internet/", "https://theobjective.com/etiqueta/smartphones/", "https://theobjective.com/etiqueta/redes-sociales/", "https://theobjective.com/etiqueta/historia/", "https://theobjective.com/etiqueta/historias-de-la-historia/", "https://theobjective.com/medios/", "https://theobjective.com/medios/television/", "https://theobjective.com/medios/radio/", "https://theobjective.com/etiqueta/programas/", "https://theobjective.com/ultimas-noticias/", "https://theobjective.com/videos/", "https://theobjective.com/etiqueta/entrevistas/", "https://theobjective.com/etiqueta/el-purgatorio/", "https://theobjective.com/etiqueta/vidas-cruzadas/", "https://theobjective.com/podcasts/", "https://theobjective.com/etiqueta/al-tanto/", "https://theobjective.com/etiqueta/el-gris-importa/", "https://theobjective.com/etiqueta/sumario-de-tarde/", "https://theobjective.com/galerias/", "https://theobjective.com/productos-recomendados/", "https://informativoscanarias.theobjective.com/", "https://classpaper.theobjective.com/", "https://theobjective.com/quienes-somos/", "https://theobjective.com/principios-y-valores/", "https://theobjective.com/equipo/", "https://theobjective.com/firmas/", "https://theobjective.com/app/", "https://theobjective.com/escuela-ethos/", "https://theobjective.com/newsletters", "https://theobjective.com/apoya-a-the-objective", "https://theobjective.com/sociedad/", "https://theobjective.com/autor/the-objective/", "https://theobjective.com/autor/the-objective/", "https://twitter.com/TheObjective_es", "//www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2020-05-22%2Funa-vacuna-china-prueba-con-exito-su-seguridad-y-capacidad-para-generar-anticuerpos%2F", "//twitter.com/intent/tweet?url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2020-05-22%2Funa-vacuna-china-prueba-con-exito-su-seguridad-y-capacidad-para-generar-anticuerpos%2F&text=Una%20vacuna%20china%20prueba%20con%20%C3%A9xito%20su%20seguridad%20y%20capacidad%20para%20generar%20anticuerpos&via=TheObjective_es", "//web.whatsapp.com/send?text=Una%20vacuna%20china%20prueba%20con%20%C3%A9xito%20su%20seguridad%20y%20capacidad%20para%20generar%20anticuerpos | The Objective%20https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2020-05-22%2Funa-vacuna-china-prueba-con-exito-su-seguridad-y-capacidad-para-generar-anticuerpos%2F", "https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2020-05-22%2Funa-vacuna-china-prueba-con-exito-su-seguridad-y-capacidad-para-generar-anticuerpos%2F&title=Una%20vacuna%20china%20prueba%20con%20%C3%A9xito%20su%20seguridad%20y%20capacidad%20para%20generar%20anticuerpos", "//telegram.me/share/url?url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2020-05-22%2Funa-vacuna-china-prueba-con-exito-su-seguridad-y-capacidad-para-generar-anticuerpos%2F&text=Una%20vacuna%20china%20prueba%20con%20%C3%A9xito%20su%20seguridad%20y%20capacidad%20para%20generar%20anticuerpos%20The Objective", "/cdn-cgi/l/email-protection#330c404651595650470e675616010343465657561601035a5d475641564052411d1d1d15515c574a0e665d52160103455250465d52160103505b5a5d52160103434146565152160103505c5d16010316700016720a4b5a475c160103404616010340565446415a5752571601034a16010350524352505a5752571601034352415216010354565d56415241160103525d475a50465641435c401601035b47474340160072160175160175475b565c51595650475a45561d505c5e160175405c505a56575257160175010301031e03061e0101160175465d521e455250465d521e505b5a5d521e4341465651521e505c5d1e564b5a475c1e40461e40565446415a5752571e4a1e50524352505a5752571e435241521e54565d564152411e525d475a50465641435c40160175", "https://www.eurekalert.org/pub_releases/2020-05/tl-tlf052220.php", "http://www.cansinotech.com/homes/article/show/56/153.html", "https://theobjective.com/autor/the-objective/", "https://theobjective.com/autor/the-objective/", "https://twitter.com/TheObjective_es", "//www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2020-05-22%2Funa-vacuna-china-prueba-con-exito-su-seguridad-y-capacidad-para-generar-anticuerpos%2F", "//twitter.com/intent/tweet?url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2020-05-22%2Funa-vacuna-china-prueba-con-exito-su-seguridad-y-capacidad-para-generar-anticuerpos%2F&text=Una%20vacuna%20china%20prueba%20con%20%C3%A9xito%20su%20seguridad%20y%20capacidad%20para%20generar%20anticuerpos&via=TheObjective_es", "//web.whatsapp.com/send?text=Una%20vacuna%20china%20prueba%20con%20%C3%A9xito%20su%20seguridad%20y%20capacidad%20para%20generar%20anticuerpos | The Objective%20https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2020-05-22%2Funa-vacuna-china-prueba-con-exito-su-seguridad-y-capacidad-para-generar-anticuerpos%2F", "https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2020-05-22%2Funa-vacuna-china-prueba-con-exito-su-seguridad-y-capacidad-para-generar-anticuerpos%2F&title=Una%20vacuna%20china%20prueba%20con%20%C3%A9xito%20su%20seguridad%20y%20capacidad%20para%20generar%20anticuerpos", "//telegram.me/share/url?url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2020-05-22%2Funa-vacuna-china-prueba-con-exito-su-seguridad-y-capacidad-para-generar-anticuerpos%2F&text=Una%20vacuna%20china%20prueba%20con%20%C3%A9xito%20su%20seguridad%20y%20capacidad%20para%20generar%20anticuerpos%20The Objective", "/cdn-cgi/l/email-protection#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", "https://news.google.com/publications/CAAiELumQ8m_nwDuO-xzhLPkxhgqFAgKIhC7pkPJv58A7jvsc4Sz5MYY?ceid=ES:es&oc=3", "https://theobjective.com/etiqueta/china/", "https://theobjective.com/etiqueta/estados-unidos/", "https://theobjective.com/etiqueta/salud/", "https://theobjective.com/etiqueta/the-objective/", "https://theobjective.com/etiqueta/vacuna-coronavirus/", "https://theobjective.com/apoya-a-the-objective/", "https://theobjective.com/espana/2020-05-28/inglaterra-y-escocia-inician-su-programa-de-rastreo-de-contagios-de-covid-19/", "https://theobjective.com/espana/2020-05-28/inglaterra-y-escocia-inician-su-programa-de-rastreo-de-contagios-de-covid-19/", "https://theobjective.com/sociedad/2020-05-27/bruselas-propone-un-fondo-de-recuperacion-de-750-000-millones-del-que-espana-e-italia-serian-los-principales-beneficiarios/", "https://theobjective.com/sociedad/2020-05-27/bruselas-propone-un-fondo-de-recuperacion-de-750-000-millones-del-que-espana-e-italia-serian-los-principales-beneficiarios/", "https://theobjective.com/sociedad/2020-05-28/estados-unidos-supera-las-100-000-muertes-por-covid-19/", "https://theobjective.com/sociedad/2020-05-28/estados-unidos-supera-las-100-000-muertes-por-covid-19/", "https://theobjective.com/espana/2020-05-29/grecia-anuncia-los-29-primeros-paises-de-los-que-aceptara-turistas-y-espana-no-esta-en-la-lista/", "https://theobjective.com/espana/2020-05-29/grecia-anuncia-los-29-primeros-paises-de-los-que-aceptara-turistas-y-espana-no-esta-en-la-lista/", "https://theobjective.com/sociedad/2020-05-28/seul-endurece-las-medidas-de-distanciamiento-y-cierra-sitios-publicos-ante-un-repunte-de-casos/", "https://theobjective.com/tecnologia/2020-05-29/trump-aviva-su-pulso-con-twitter-y-firma-una-orden-contra-las-redes-sociales/", "https://theobjective.com/sociedad/2020-05-28/trasplantan-los-dos-pulmones-a-un-italiano-de-18-anos-que-contrajo-el-covid-19/", "https://theobjective.com/sociedad/2020-05-28/la-pandemia-de-covid-19-dispara-el-riesgo-para-los-civiles-en-zonas-de-guerra/", "https://theobjective.com/espana/", "https://theobjective.com/espana/politica/", "https://theobjective.com/espana/tribunales/", "https://theobjective.com/etiqueta/madrid/", "https://theobjective.com/etiqueta/cataluna/", "https://theobjective.com/espana/andalucia/", "https://theobjective.com/economia/", "https://theobjective.com/etiqueta/macroeconomia/", "https://theobjective.com/etiqueta/banca/", "https://theobjective.com/etiqueta/telecos/", "https://theobjective.com/etiqueta/energia/", "https://theobjective.com/etiqueta/transporte/", "https://theobjective.com/elsubjetivo/", "https://theobjective.com/elsubjetivo/opinion/", "https://theobjective.com/autor/alvaro-nieto/", "https://theobjective.com/autor/felix-de-azua/", "https://theobjective.com/autor/fernando-savater/", "https://theobjective.com/autor/antonio-cano/", "https://theobjective.com/sociedad/", "https://theobjective.com/cultura/", "https://theobjective.com/deportes/", "https://theobjective.com/internacional/", "https://theobjective.com/economia/consumo/", "https://theobjective.com/lifestyle/", "https://theobjective.com/gastronomia/", "https://theobjective.com/etiqueta/moda/", "https://theobjective.com/etiqueta/belleza/", "https://theobjective.com/etiqueta/sexualidad/", "https://theobjective.com/gente/", "https://theobjective.com/videos/", "https://theobjective.com/podcasts/", "https://theobjective.com/ultimas-noticias/", "https://theobjective.com/etiqueta/entrevistas/", "https://theobjective.com/branded-content/", "https://theobjective.com/etiqueta/vidas-cruzadas/", "https://theobjective.com/etiqueta/contraluz/", "https://theobjective.com/etiqueta/la-mirilla/", "https://theobjective.com/etiqueta/el-buzon-secreto/", "https://theobjective.com/etiqueta/historias-de-la-historia/", "https://theobjective.com/quienes-somos/", "https://theobjective.com/equipo/", "https://theobjective.com/newsletters/", "https://theobjective.com/apoya-a-the-objective/", "https://theobjective.com/escuela-ethos/", "https://theobjective.com/quienes-somos/", "https://theobjective.com/equipo/", "https://theobjective.com/politica-de-privacidad/", "https://theobjective.com/politica-de-cookies/", "https://theobjective.com/aviso-legal/", "https://theobjective.com/contactanos/", "https://theobjective.com/newsletters", "https://theobjective.com/terminos-y-condiciones", "https://theobjective.com/politica-de-privacidad", "https://theobjective.com"]}